@article{cad95f91a88841c2aff00bdb84310a82,
title = "Scientific Advances in Thoracic Oncology 2016",
abstract = "Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.",
keywords = "Adjuvant therapy, Biomarkers, Cancer prevention, Immunotherapy, Malignant mesothelioma, Molecular diagnostics, NSCLC, Pathology, Radiotherapy, SCLC, Screening, Smoking cessation, Staging, Surgery, Targeted therapy, Value of therapy",
author = "Soo, {Ross A.} and Stone, {Emily C.A.} and Cummings, {K. Michael} and Jett, {James R.} and Field, {John K.} and Groen, {Harry J.M.} and Mulshine, {James L.} and Yasushi Yatabe and Lukas Bubendorf and Sanja Dacic and Ramon Rami-Porta and Detterbeck, {Frank C.} and Eric Lim and Hisao Asamura and Jessica Donington and Wakelee, {Heather A.} and Wu, {Yi Long} and Kristin Higgins and Suresh Senan and Benjamin Solomon and Kim, {Dong Wan} and Melissa Johnson and Yang, {James C.H.} and Sequist, {Lecia V.} and Shaw, {Alice T.} and Ahn, {Myung Ju} and Costa, {Daniel B.} and Patel, {Jyoti D.} and Leora Horn and Scott Gettinger and Solange Peters and Wynes, {Murry W.} and Corinne Faivre-Finn and Rudin, {Charles M.} and Anne Tsao and Paul Baas and Kelly, {Ronan J.} and Leighl, {Natasha B.} and Scagliotti, {Giorgio V.} and Gandara, {David R.} and Hirsch, {Fred R.} and Spigel, {David R.}",
note = "Funding Information: This work was funded in part through a Lung Cancer Foundation of America–International Association for the Study of Lung Cancer grant (to Dr. Costa), an American Cancer Society grant RSG 11-186 (to Dr. Costa), and National Cancer Institute grant CA090578 (to Dr. Costa). The CONVERT trial was funded by a Cancer Research UK grant (Dr. Faivre-Finn). The Editors would like to acknowledge all coauthors for providing a succinct and expert commentary in a swift manner and thank Managing Editor Murry Wynes for outstanding editorial assistance. Publisher Copyright: {\textcopyright} 2017 International Association for the Study of Lung Cancer",
year = "2017",
month = aug,
doi = "10.1016/j.jtho.2017.05.019",
language = "English (US)",
volume = "12",
pages = "1183--1209",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "8",
}